{"id":"W3015551664","doi":"10.1111/jdv.16433","title":"Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Dermatology Life Quality Index; Janus kinase inhibitor; Psoriasis; Psoriasis Area and Severity Index; Placebo; Dermatology; Adalimumab; Internal medicine; Randomized controlled trial; Arthritis; Quality of life (healthcare); Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01228561,0.001952461,0.00494646,0.000895262,0.0009989172,0.00219704,0.001095648,0.002545331,0.007173091],"category_scores_gemma":[0.008312704,0.0009306764,0.009209871,0.001335721,0.001244068,0.001572783,0.000936616,0.002694178,0.0005602396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001500277,"about_ca_system_score_gemma":0.002414545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023022,"about_ca_topic_score_gemma":0.002894315,"domain_scores_codex":[0.9937508,0.00394305,0.0007432725,0.0005255328,0.0006140218,0.0004234182],"domain_scores_gemma":[0.9934958,0.002275532,0.002237599,0.0004832802,0.0005763068,0.0009314723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9552788,0.004174384,0.002749192,0.002717135,0.01304978,0.00004907763,0.00007866583,0.0003476455,0.001559388,0.00008527628,0.0009236833,0.0189871],"study_design_scores_gemma":[0.95022,0.03365655,0.00731425,0.0001938027,0.006937664,0.00005490416,0.00003137505,0.0002036862,0.0002350503,0.0001680316,0.0009570813,0.00002758455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9035462,0.05592851,0.002831516,0.001959586,0.0008427924,0.02149256,0.008067463,0.0002399243,0.005091358],"genre_scores_gemma":[0.9556957,0.01304079,0.003020162,0.002655799,0.0006991875,0.01874232,0.004799382,0.00004289526,0.001303674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01228561,"threshold_uncertainty_score":0.06497329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05503634845907841,"score_gpt":0.3493281288000192,"score_spread":0.2942917803409408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}